These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1101 related items for PubMed ID: 22614698
1. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder. Blick C, Hall P, Pwint T, Al-Terkait F, Crew J, Powles T, Macaulay V, Munro N, Douglas D, Kilbey N, Protheroe A, Chester JD. Cancer; 2012 Aug 15; 118(16):3920-7. PubMed ID: 22614698 [Abstract] [Full Text] [Related]
2. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N. Urology; 2004 Sep 15; 64(3):488-93. PubMed ID: 15351577 [Abstract] [Full Text] [Related]
7. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors. Angulo JC, Sanchez-Chapado M, Lopez JI, Flores N. J Urol; 1996 Jun 15; 155(6):1897-902. PubMed ID: 8618282 [Abstract] [Full Text] [Related]
9. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan. Matsui Y, Nishiyama H, Watanabe J, Teramukai S, Ono Y, Ohshima S, Fujimoto K, Hirao Y, Fukushima M, Ogawa O. Int J Clin Oncol; 2005 Apr 15; 10(2):133-8. PubMed ID: 15864700 [Abstract] [Full Text] [Related]
10. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet; 1999 Aug 14; 354(9178):533-40. PubMed ID: 10470696 [Abstract] [Full Text] [Related]
11. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R. J Urol; 1995 Jan 14; 153(1):47-52. PubMed ID: 7966789 [Abstract] [Full Text] [Related]
12. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study]. Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A. Arch Esp Urol; 1997 Jun 14; 50(5):448-54; discussion 454-6. PubMed ID: 9382586 [Abstract] [Full Text] [Related]
14. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study. Vikram B, Chadha M, Malamud SC, Hecht H, Grabstald H. Cancer; 1998 Mar 01; 82(5):918-22. PubMed ID: 9486582 [Abstract] [Full Text] [Related]
17. Can patient selection for bladder preservation be based on response to chemotherapy? Sternberg CN, Pansadoro V, Calabrò F, Schnetzer S, Giannarelli D, Emiliozzi P, De Paula F, Scarpone P, De Carli P, Pizzo M, Platania A, Amini M. Cancer; 2003 Apr 01; 97(7):1644-52. PubMed ID: 12655521 [Abstract] [Full Text] [Related]
18. [Neoadjuvant chemotherapy (M-VAC) in invasive cancer of the bladder. Our experience]. González Enguita C, Caro Cebrián C, Roncalés Badal A, Gil Sanz MJ, Martínez Bengoechea J, Rioja Sanz LA. Arch Esp Urol; 1990 Apr 01; 43 Suppl 2():197-204. PubMed ID: 2096779 [Abstract] [Full Text] [Related]
19. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. Freiha F, Reese J, Torti FM. J Urol; 1996 Feb 01; 155(2):495-9; discussion 499-500. PubMed ID: 8558644 [Abstract] [Full Text] [Related]